Acute asthma exacerbation in adults

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão: 20 Jul 2025
Última atualização: 15 Apr 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • cough
  • wheezing
  • shortness of breath
  • chest tightness
  • sleep disturbance
  • accessory muscle use
  • tachypnea
  • tachycardia
  • wheezing, poor air movement, or diminished breath sounds
  • inability to speak
Detalhes completos

Outros fatores diagnósticos

  • exercise limitation
  • altered consciousness
  • stridor
  • cyanosis
Detalhes completos

Fatores de risco

  • viral infection
  • uncontrolled asthma symptoms
  • high use of short-acting beta-2 agonists
  • inconsistent use of inhaled corticosteroids
  • incorrect inhaler technique
  • low forced expiratory volume in 1 second (FEV₁)
  • high bronchodilator responsiveness
  • current smoker (including e-cigarettes/vapes) or exposure to secondhand cigarette smoke
  • exposure to allergens (including history of seasonal allergic rhinitis)
  • air pollution
  • poor indoor air quality
  • obesity
  • chronic rhinosinusitis
  • gastroesophageal reflux disease
  • confirmed food allergy
  • history of asthma
  • history of hospitalization for asthma exacerbations
  • one or more severe exacerbations in the last 12 months
  • use of oral corticosteroids
  • poor adherence to asthma treatment
  • pregnancy
  • psychological or socioeconomic problems
  • elevated blood eosinophils
  • elevated fractional exhaled nitric oxide (FeNO)
  • respiratory bacterial infection
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • oxygen saturation
  • peak expiratory flow rate
Detalhes completos

Investigações a serem consideradas

  • ABG
  • chest x-ray
  • CBC
  • metabolic panel for electrolytes, BUN levels, creatinine
Detalhes completos

Algoritmo de tratamento

AGUDA

life-threatening exacerbation or impending respiratory failure

severe exacerbation

mild to moderate exacerbation

CONTÍNUA

symptomatic asthma

Colaboradores

Consultores especialistas

Sourav Majumdar, MD

Clinical Assistant Professor (Affiliated)

Division of Pulmonary, Allergy and Critical Care Medicine

Department of Medicine

Stanford University School of Medicine

Stanford

CA

Declarações

SM declares that he has no competing interests.

Lauren Eggert, MD

Clinical Assistant Professor

Division of Pulmonary, Allergy and Critical Care Medicine

Department of Medicine

Stanford University School of Medicine

Stanford

CA

Declarações

LE declares that she has participated on advisory boards for Regeneron and AstraZeneca.

Agradecimentos

Dr Sourav Majumdar and Dr Lauren Eggert would like to gratefully acknowledge Dr Ware Kuschner, Dr Michael Ezzie, and Dr Jonathan P. Parsons, the previous contributors to this topic.

Declarações

WK and ME declare that they have no competing interests. JPP is a member of Speakers' Bureaus for GlaxoSmithKline, Schering-Plough, and AstraZeneca.

Revisores

Anne Dixon, MD

Assistant Professor

Pulmonary and Critical Care Medicine

University of Vermont

Burlington

VT

Declarações

AD declares that she has no competing interests.

Neil C. Thomson, MBChB, MD, FRCP

Professor of Respiratory Medicine

Institute of Infection, Immunity & Inflammation

University of Glasgow

Glasgow

Scotland

UK

Declarações

NCT declares that he has no competing interests.

Graeme P. Currie, MBChB, MD, FRCP

Consultant Chest Physician

Chest Clinic C

Aberdeen Royal Infirmary

Aberdeen

Scotland

UK

Declarações

GPC declares that he has no competing interests.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. May 2024 [internet publication].Texto completo

Cloutier MM, Baptist AP, Teach SJ, et al; Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC). 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020 Dec;146(6):1217-70.Texto completo  Resumo

British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Nov 2024 [internet publication].Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Pneumonia
    • Foreign body/obstruction
    • Vocal cord dysfunction
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Global strategy for asthma management and prevention​
    • 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group
    Mais Diretrizes
  • Videos

    Peak flow measurement: animated demonstration

    Expiratory wheeze

    Mais vídeos
  • Folhetos informativos para os pacientes

    Asthma in adults

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal